Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
10.55
-0.51 (-4.57%)
At close: Jun 5, 2026, 4:00 PM EDT
10.55
+0.01 (0.05%)
After-hours: Jun 5, 2026, 4:15 PM EDT
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $362.27 million as of June 5, 2026. Its market cap has increased by 3.56% in one year.
Market Cap
362.27M
Enterprise Value
178.55M
1-Year Change
3.56%
Ranking
Category
Stock Price
$10.55
Market Cap Chart
Since June 26, 2014, Benitec Biopharma's market cap has decreased from $2.23B to $362.27M, a decrease of -83.73%. That is a compound annual growth rate of -14.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 362.44M | -20.54% |
| Dec 31, 2025 | 456.12M | 55.56% |
| Dec 31, 2024 | 293.22M | 3,429.00% |
| Dec 29, 2023 | 8.31M | 74.68% |
| Dec 30, 2022 | 4.76M | -77.78% |
| Dec 31, 2021 | 21.41M | 61.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Conexeu Sciences | 385.23M |
| Century Therapeutics | 384.16M |
| Upstream Bio | 383.66M |
| Prelude Therapeutics | 377.87M |
| Compass Therapeutics | 367.38M |
| Vanda Pharmaceuticals | 362.62M |
| X4 Pharmaceuticals | 361.24M |
| OmniAb | 359.53M |